- Molecular NameEthionamide
- SynonymET; ETH; Ethinamide; Ethionamid prothionamid; Ethionamidum [INN-Latin]; Ethioniamide; Ethylisothiamide; Ethyonomide; Etionamid; Etionamida [INN-Spanish]; Etionamide [DCIT]; Etioniamid; ETP
- Weight166.248
- Drugbank_IDDB00609
- ACS_NO536-33-4
- Show 3D model
- LogP (experiment)N/A
- LogP (predicted, AB/LogP v2.0)1.56
- pkaN/A
- LogD (pH=7, predicted)1.56
- Solubility (experiment)Insoluble
- LogS (predicted, ACD/Labs)(ph=7)-1.59
- LogSw (predicted, AB/LogsW2.0)3.22
- Sw (mg/ml) (predicted, ACD/Labs)4.26
- No.of HBond Donors2
- No.of HBond Acceptors2
- No.of Rotatable Bonds2
- TPSA71.0
- StatusFDA approved
- AdministrationN/A
- PharmacologyAn antibiotic used in the treatment of tuberculosis.
- Absorption_value100.0
- Absorption (description)Readily absorbed after oral administration and widely distributed throughout the body.
- Caco_2N/A
- Bioavailability80.0
- Protein binding30.0
- Volume of distribution (VD)N/A
- Blood/Plasma Partitioning ratio (D_blood)N/A
- MetabollsmIt is extensively metabolised and is excreted in the urine mainly as metabolites with little unchanged drug. The metabolites include ethionamide sulfoxide, 2-ethylisonicotinic acid and 2-ethylisonicotinamide.
- Half life2~3 h
- ExcretionUrine (<1% as unchanged drug; as active and inactive metabolites)
- Urinary ExcretionN/A
- CleranceN/A
- ToxicitySymptoms of overdose include convulsions, nausea, and vomiting.
- LD50 (rat)N/A
- LD50 (mouse)N/A